SEC 13F Intelligence

Altium Capital Management LLC / MYGN

Altium Capital Management LLC’s Myriad Genetics Inc Position

Does Altium Capital Management LLC own Myriad Genetics Inc (MYGN)? Not currently — the last reported position was 180.0K shares worth $4M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q1 2023
Shares
180.0K
% of Portfolio
+2.32%
Quarters Held
10
position exited

Position History MYGN

Reported value by quarter
Q4 ’20: $4MQ4 ’20Q1 ’21: $5MQ2 ’21: $5MQ2 ’21Q3 ’21: $5MQ4 ’21: $5MQ4 ’21Q1 ’22: $3MQ2 ’22: $4MQ2 ’22Q3 ’22: $4MQ4 ’22: $3MQ4 ’22Q1 ’23: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2023180.0K$4M+2.32%
Q4 2022212.0K$3M+1.56%
Q3 2022186.0K$4M+1.30%
Q2 2022221.0K$4M+1.61%
Q1 2022114.7K$3M+0.97%
Q4 2021190.0K$5M+1.45%
Q3 2021158.0K$5M+1.34%
Q2 2021171.2K$5M+1.21%
Q1 2021171.8K$5M+1.45%
Q4 2020218.7K$4M+1.61%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of MYGN.